New drug aims to cut blood transfusions for bone marrow disease patients
NCT ID NCT05320198
First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 4 times
Summary
This study tests an experimental drug called DISC-0974 in about 150 adults with myelofibrosis or myelodysplastic syndrome (MDS) who also have anemia. The goal is to see if the drug can reduce the need for blood transfusions and increase red blood cell levels. The study is in early and middle phases, focusing on safety and effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Atrium Health Wake Forest Baptist
RECRUITINGWinston-Salem, North Carolina, 27157, United States
-
Banner MD Anderson
RECRUITINGGilbert, Arizona, 85234, United States
-
City of Hope - Duarte
RECRUITINGDuarte, California, 91010, United States
-
City of Hope - Lennar
RECRUITINGIrvine, California, 92618, United States
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
-
Emory Winship Cancer Institute
RECRUITINGAtlanta, Georgia, 30322, United States
-
Gabrail Cancer Center Research
TERMINATEDCanton, Ohio, 44718, United States
-
Icahn School of Medicine at Mount Sinai
RECRUITINGNew York, New York, 10029, United States
-
Linear Clinical Research
RECRUITINGNedlands, 6009, Australia
-
MD Anderson
RECRUITINGHouston, Texas, 77030, United States
-
Mayo Clinic Jacksonville
RECRUITINGJacksonville, Florida, 32224, United States
-
Mayo Clinic Rochester
RECRUITINGRochester, Minnesota, 55905, United States
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10021, United States
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
-
Montefiore
RECRUITINGNew York, New York, 10467, United States
-
Oregon Health and Science University
RECRUITINGPortland, Oregon, 97239, United States
-
Perth Blood Institute
RECRUITINGWest Perth, 6005, Australia
-
Sargon Research - Pennsylvania Cancer Specialists and Research Center
WITHDRAWNGettysburg, Pennsylvania, 17325, United States
-
St. Vincent's Hospital
RECRUITINGSydney, 2010, Australia
-
Sylvester Cancer Center - U Miami
RECRUITINGMiami, Florida, 33136, United States
-
The Ohio State University
RECRUITINGColumbus, Ohio, 43201, United States
-
UCLA
RECRUITINGLos Angeles, California, 90095, United States
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
-
University of Colorado Anschutz Medical Campus
RECRUITINGAurora, Colorado, 80045, United States
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
University of Washington
RECRUITINGSeattle, Washington, 98109, United States
-
Washington University St.Louis
RECRUITINGSt Louis, Missouri, 63110, United States
-
Western Health
RECRUITINGSaint Albans, 3021, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can less be more? testing transfusion limits in ECMO
- Can a Dual-Action pill tame bone marrow tumors?
- A simple blood test trend may flag ICU patients at risk
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?